Omega Therapeutics Inc (OMGA) - Market Cap to Net Income Ratio

Symbol and logo of brand Omega Therapeutics Inc (OMGA)

This daily price chart for Omega Therapeutics (OMGA), whose indicator stands at -0.10, is based on the achievements of a team of mRNA programming experts and scarce bioinformaticians. The production cycle relies on laboratories in Massachusetts and external CDMO sites to ensure cGMP compliance. However, the business faces a fierce battle over patents and pressure from gene therapy behemoths.

omegatherapeutics.com (OMGA): Price to Earnings Ratio from 07/04/2022 to 03/01/2025

Comprehensive metric breakdowns and analytics for Omega (OMGA)

- market price and analyst price targets:
Market Price omegatherapeutics.com|OMGA - Analyst Consensus Forecast
- market capitalization indicators:
Market Capitalization Omega Therapeutics, Inc.|OMGA - Enterprise Value
- shareholders' equity book value data:
Book Value per Share Omega Therapeutics|OMGA - Company Net Assets|Market Value to Book Value omegatherapeutics.com|OMGA - Cumulative Company Assets
- debt and solvency information:
Aggregate Debt to Capital Omega Therapeutics|OMGA - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Omega Therapeutics Corp|OMGA - Company Aggregate Debts|Debts to Book Value Omega Therapeutics, Inc.|OMGA - Company Long-Term Debt|Company Short-Term Loans and Borrowings Omega Therapeutics|Quick Ratio omegatherapeutics.com
- net income and valuation ratios data:
OMGA - Company Net Income|Forward Earnings Omega Therapeutics|OMGA - P/E Multiple|Projected Price to Earnings Ratio Omega Therapeutics Inc|OMGA - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Omega Therapeutics, Inc.|OMGA - Operating profit before deduction of amortization|Earnings per share for the last four quarters Omega Therapeutics|OMGA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months omegatherapeutics.com|OMGA - Earnings growth in current year|Expected earnings per share growth for next year Omega Therapeutics
Summary company analysis:OMGA (omegatherapeutics.com)
Finished products of Omega Therapeutics Corp

The market values Omega Therapeutics (OMGA) through the lens of its epigenomic technology potential. The P/E ratio correlates the stock's market value with net income, determining the investment payback period. By analyzing the company's P/E chart, an investor can see the gap between the speculative price and the actual value of the assets. For the developers of the OMEGA platform, this indicator reflects expectations for future drugs. The stability of this metric confirms the long-term sustainability of the business.

Analysis of competing companies

Market Cap to Earnings Tempus AI Inc TEM|P/E Multiple QGEN|Ionis Pharmaceuticals, Inc. (IONS) - Market Cap to Net Income Ratio|P/E Multiple RGEN (Repligen Corp.)|P/E Multiple Avidity Corp RNA|CRSP: Price to Earnings Ratio|Company Value to Net Income WGS (genedx.com)|RARE (Ultragenyx) - Price to Earnings Ratio|BEAM: Market Price to Net Income Ratio|SRPT (Sarepta Therapeutics Inc) - P/E Multiple|TWST: Company Value to Net Income|P/E Multiple TXG|NTLA - Market Cap to Earnings|Price to Earnings Ratio Stoke Therapeutics, Inc. STOK|Company Value to Net Income BLFS|Wave Life Sciences Corp - P/E Multiple|MAZE - P/E Multiple|Sionna Therapeutics Inc (SION) - Price to Earnings Ratio|Market Cap to Net Income PRME (primemedicine.com)|TSHA (Taysha Gene Therapies, Inc.) - P/E Multiple|Market Cap to Earnings uniQure NV QURE|Price to Earnings Ratio MGTX (MeiraGTx PLC)|P/E Multiple REGENXBIO Corp (RGNX)|Solid Biosciences Inc. - Price to Earnings Ratio|Market Price to Net Income Ratio OCGN (ocugen.com)|PacBio - P/E Multiple|Business Payback Period Benitec Biopharma Inc BNTC|DSGN: P/E Multiple|Price to Earnings Ratio Rocket Corp|Price to Earnings Ratio 4D Molecular Therapeutics|Lexeo (LXEO) - Business Payback Period|Price to Earnings Ratio Korro Bio, Inc. (KRRO)|EDIT - Market Cap to Earnings|Price to Earnings Ratio Silence Therapeutics Inc. SLN|PRQR - Price to Earnings Ratio|Codexis Bio - P/E Multiple|Market Cap to Net Income Ratio sangamo.com (SGMO)|NAUT: P/E Multiple|Metagenomi Inc. (MGX) - P/E Multiple|DTIL (Precision BioSciences, Inc.) - P/E Multiple|Price to Earnings Multiple GBIO (Generation Bio Corp)|Price to Earnings Ratio Boundless Bio, Inc. (BOLD)|exicuretx.com - Price to Earnings Multiple|P/E Multiple IMNN (Imunon)|P/E Multiple Phio Pharmaceuticals Corp PHIO|MBIO - Price to Earnings Ratio|Market Cap to Earnings TransCode Therapeutics|bionanogenomics.com (BNGO) - Price to Earnings Ratio|Price to Earnings Ratio adnas.com|BLUE (bluebird bio) - P/E Multiple|Market Cap to Earnings ImmunoPrecise IPA|P/E Multiple OMIC|Regulus (RGLS) - Market Cap to Net Income Ratio|P/E Multiple SYRS (Syros Pharmaceuticals)|P/E Multiple telesisbio.com TBIO|TCON: Price to Earnings Ratio|Company Value to Net Income UBX (Unity Biotechnology Inc.)